PTCT

PTC Therapeutics, Inc. Press Releases

$71.33
*  
2.13
2.9%
Get PTCT Alerts
*Delayed - data as of Feb. 27, 2015  -  Find a broker to begin trading PTCT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update
2/27/2015 8:00:00 AM - PR Newswire


Intersil's New Four-Channel Video Decoder Provides Stunning Image Quality for Improved Automotive Safety
2/16/2015 8:00:00 AM - PR Newswire


PTC Therapeutics to Participate at Upcoming March Investor Conferences
2/16/2015 8:00:00 AM - PR Newswire


PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year End 2014 Financial Results
2/13/2015 4:30:00 PM - PR Newswire


PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2/6/2015 5:00:00 PM - PR Newswire


PTC Therapeutics to Participate at Upcoming Investor Conferences
2/5/2015 4:30:00 PM - PR Newswire


PTC Therapeutics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/7/2015 8:00:00 AM - PR Newswire
▲39.67 % Price Change since this news event. The Volume Ratio is 1.05.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
1/2/2015 5:15:00 PM - PR Newswire
▲39.86 % Price Change since this news event. The Volume Ratio is 1.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Begins Rolling NDA Submission to the FDA for Translarna to Treat Duchenne Muscular Dystrophy
12/23/2014 8:00:00 AM - PR Newswire
▲29.10 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I
12/19/2014 8:00:00 AM - PR Newswire
▲27.95 % Price Change since this news event. The Volume Ratio is 3.31.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12/17/2014 4:30:00 PM - PR Newswire
▲40.19 % Price Change since this news event. The Volume Ratio is 1.06.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


PTC Therapeutics Announces Launch of Translarna™ (ataluren) in Germany
12/3/2014 8:00:00 AM - PR Newswire
▲49.29 % Price Change since this news event. The Volume Ratio is 0.75.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day